Effect of Pioglitazone on Inflammatory Response and Clinical Outcome in T2DM Patients with COVID-19: a Randomized Multicenter Double-Blind Clinical Trial Khaled Baagar , Thamer Alessa , Mohamed Abu-Farha , Jehad Abubaker , Heba Alhumaidi , Jose Antonio Franco Ceruto , Mohammad Khair Hamad , Ali Omrani , Salma Abdelrahman , Muhammad Zaka-Ul Haq , Abdul Wajid Safi , Bassem Alhariri , Manish Barman , Alaaeldin Abdelmajid , Humberto Vidal Denis Cancio , Eman Elmekaty , Irina Al-Khairi , Preethi Cherian , Lina Jayyousi , Mohammed Ahmed , Mohammed Qaddoumi , Sulaiman Hajji , Ahmad Esmaeel , Ali Al-Andaleeb , Arshad Channanath , Sriraman Devarajan , Hamad Ali , Thangavel Alphonse Thanaraj , Salman Al-Sabah , Fahd Al-Mulla , Muhammad Abdul-Ghani , Amin Jayyousi Frontiers in Immunology（2024）
关键词
COVID-19, SARS-CoV-2, inflammation, type 2 diabetes, pioglitazone
AI 理解论文
溯源树
样例
